BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D.s. PB, Medhi B, Prakash A, Chakrabarti A, Vaiphei K, Khanduja KL. Comparative evaluation of different doses of PPAR-γ agonist alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats. Pharmacological Reports 2013;65:951-9. [DOI: 10.1016/s1734-1140(13)71076-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Cagin YF, Parlakpinar H, Vardi N, Polat A, Atayan Y, Erdogan MA, Tanbek K. Effects of dexpanthenol on acetic acid-induced colitis in rats. Exp Ther Med 2016;12:2958-64. [PMID: 27882101 DOI: 10.3892/etm.2016.3728] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
2 Pan J, Jin JL, Ge HM, Yin KL, Chen X, Han LJ, Chen Y, Qian L, Li XX, Xu Y. Malibatol A regulates microglia M1/M2 polarization in experimental stroke in a PPARγ-dependent manner. J Neuroinflammation 2015;12:51. [PMID: 25889216 DOI: 10.1186/s12974-015-0270-3] [Cited by in Crossref: 99] [Cited by in F6Publishing: 103] [Article Influence: 14.1] [Reference Citation Analysis]
3 Baek JS, Yeo EW, Lee YH, Tan NS, Loo SCJ. Controlled-release nanoencapsulating microcapsules to combat inflammatory diseases. Drug Des Devel Ther 2017;11:1707-17. [PMID: 28652708 DOI: 10.2147/DDDT.S133344] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]